Abstract
Hybrid molecules have been developed which are comprised of a tyrosine kinase-targeted, quinazoline-based scaffold and a flexibly linked dia(m)minechloridoPt(ii) moiety. The target compounds maintain high affinity and selectivity for ErbB family kinase proteins and one of the derivatives induces platinum adducts with a pharmacologically important cysteine residue.
Original language | English (US) |
---|---|
Pages (from-to) | 7479-7482 |
Number of pages | 4 |
Journal | Chemical Communications |
Volume | 54 |
Issue number | 54 |
DOIs | |
State | Published - 2018 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2018 The Royal Society of Chemistry.